JP2022537684A5 - - Google Patents
Info
- Publication number
- JP2022537684A5 JP2022537684A5 JP2021573416A JP2021573416A JP2022537684A5 JP 2022537684 A5 JP2022537684 A5 JP 2022537684A5 JP 2021573416 A JP2021573416 A JP 2021573416A JP 2021573416 A JP2021573416 A JP 2021573416A JP 2022537684 A5 JP2022537684 A5 JP 2022537684A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- smev
- composition according
- item
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962860049P | 2019-06-11 | 2019-06-11 | |
| US201962860029P | 2019-06-11 | 2019-06-11 | |
| US62/860,029 | 2019-06-11 | ||
| US62/860,049 | 2019-06-11 | ||
| US202062979545P | 2020-02-21 | 2020-02-21 | |
| US62/979,545 | 2020-02-21 | ||
| US202062991767P | 2020-03-19 | 2020-03-19 | |
| US62/991,767 | 2020-03-19 | ||
| PCT/US2020/037201 WO2020252144A1 (en) | 2019-06-11 | 2020-06-11 | Secreted microbial extracellular vesicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537684A JP2022537684A (ja) | 2022-08-29 |
| JP2022537684A5 true JP2022537684A5 (https=) | 2023-06-15 |
Family
ID=71950732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573327A Pending JP2022538765A (ja) | 2019-06-11 | 2020-06-11 | 処理された微生物細胞外小胞 |
| JP2021573416A Pending JP2022537684A (ja) | 2019-06-11 | 2020-06-11 | 分泌された微生物細胞外小胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573327A Pending JP2022538765A (ja) | 2019-06-11 | 2020-06-11 | 処理された微生物細胞外小胞 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20220249579A1 (https=) |
| EP (2) | EP3982987A1 (https=) |
| JP (2) | JP2022538765A (https=) |
| KR (2) | KR20220020894A (https=) |
| CN (2) | CN114650831A (https=) |
| AU (2) | AU2020291434A1 (https=) |
| BR (2) | BR112021024830A2 (https=) |
| CA (2) | CA3143025A1 (https=) |
| CO (2) | CO2022000041A2 (https=) |
| MX (2) | MX2021015429A (https=) |
| TW (2) | TW202128198A (https=) |
| WO (2) | WO2020252144A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7402805B2 (ja) * | 2018-02-06 | 2023-12-21 | エヴェロ バイオサイエンシズ，インコーポレーテッド | ベイロネラ（Ｖｅｉｌｌｏｎｅｌｌａ）の細菌を使用して癌及び免疫障害を処置するための組成物及び方法 |
| KR102286042B1 (ko) * | 2019-01-09 | 2021-08-03 | 주식회사 엠디헬스케어 | 데이노코커스 속 세균 유래 나노소포 및 이의 용도 |
| JP7761556B2 (ja) * | 2019-09-18 | 2025-10-28 | リサーチ ディベロップメント ファウンデーション | 代謝性疾患および障害を治療するための方法およびプロバイオティック組成物 |
| TW202214276A (zh) * | 2020-06-11 | 2022-04-16 | 美商艾弗洛生物科技股份有限公司 | 使用ｈａｒｒｙｆｌｉｎｔｉａ ａｃｅｔｉｓｐｏｒａ治療疾病和障礙之組成物及方法 |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
| AU2021296649A1 (en) * | 2020-06-22 | 2023-02-09 | Sl Bigen, Inc. | Method and composition for enhancing cancer treatment efficacy of bacteria extracellular vesicles |
| EP4185307A1 (en) * | 2020-07-21 | 2023-05-31 | Evelo Biosciences, Inc. | Veillonella parvula strain as an oral therapy for neuroinflammatory diseases |
| TW202227110A (zh) * | 2020-09-21 | 2022-07-16 | 美商艾弗洛生物科技股份有限公司 | 用棲組織普雷沃菌調節免疫反應之組成物及方法 |
| JP2024505207A (ja) * | 2021-01-26 | 2024-02-05 | エヴェロ バイオサイエンシズ，インコーポレーテッド | プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）細胞外小胞調製物 |
| WO2022178209A1 (en) * | 2021-02-19 | 2022-08-25 | Evelo Biosciences, Inc. | Compositions and methods for treating metabolic diseases and disorders using christensenellaceae bacteria |
| WO2022221183A1 (en) * | 2021-04-12 | 2022-10-20 | Evelo Biosciences, Inc. | Fournierella extracellular vesicle preparations |
| WO2022251166A2 (en) * | 2021-05-25 | 2022-12-01 | Evelo Biosciences, Inc. | Bacterial compositions comprising soy hemoglobin |
| CN117440819A (zh) * | 2021-06-07 | 2024-01-23 | Md保健株式会社 | 包含明串珠菌属细菌来源的囊泡的用于预防或治疗炎性疾病或癌症的组合物 |
| WO2023114300A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Fournierella massiliensis bacteria extracellular vesicle preparations |
| WO2023114293A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Extracellular vesicle assays |
| WO2023146843A1 (en) * | 2022-01-25 | 2023-08-03 | Evelo Biosciences, Inc. | Extracellular vesicle compositions and methods of use |
| WO2023239728A1 (en) * | 2022-06-07 | 2023-12-14 | Evelo Biosciences, Inc. | Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles |
| JP2024167772A (ja) * | 2023-05-22 | 2024-12-04 | マイクロアルジェコーポレーション株式会社 | 免疫賦活用組成物及び発現誘導用組成物 |
| CN118006515B (zh) * | 2024-04-08 | 2024-06-18 | 中国农业大学 | 一株乳酸乳球菌及其在制备治疗牛乳腺炎的药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102394638B1 (ko) * | 2015-09-30 | 2022-05-09 | (주)아모레퍼시픽 | 유산균 유래의 세포외 소낭을 포함하는 탈모 방지 또는 육모 촉진용 조성물 |
| KR101858840B1 (ko) * | 2016-01-15 | 2018-05-16 | 단국대학교 천안캠퍼스 산학협력단 | 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제 |
| TW201906620A (zh) * | 2017-07-05 | 2019-02-16 | 美商艾弗洛生物科技股份有限公司 | 使用動物雙岐桿菌乳亞種 (bifidobacterium animalis ssp. lactis) 治療癌症之組合物及方法 |
| TW201920648A (zh) * | 2017-08-29 | 2019-06-01 | 美商艾弗洛生物科技股份有限公司 | 使用布勞特氏(blautia)菌株治療癌症 |
| EP3679057A1 (en) * | 2017-09-08 | 2020-07-15 | Evelo Biosciences, Inc. | Extracellular vesicles from prevotella |
| EP3678693A1 (en) * | 2017-09-08 | 2020-07-15 | Evelo Biosciences, Inc. | Bacterial extracellular vesicles |
| CN111601610A (zh) * | 2017-11-14 | 2020-08-28 | 伊夫罗生物科学公司 | 使用布劳特氏菌属菌株治疗疾病的组合物和方法 |
| BR112020009133A2 (pt) * | 2017-11-15 | 2020-10-13 | Evelo Biosciences, Inc. | composições e métodos de tratamento de distúrbios imunológicos usando cepas de bactérias lactococcus imunomoduladoras |
| CN109580960A (zh) * | 2019-01-14 | 2019-04-05 | 周明 | 细胞外囊泡的分离方法、以及检测细胞外囊泡表面标志物的方法和试剂盒 |
-
2020
- 2020-06-11 CA CA3143025A patent/CA3143025A1/en active Pending
- 2020-06-11 KR KR1020227000648A patent/KR20220020894A/ko not_active Withdrawn
- 2020-06-11 BR BR112021024830A patent/BR112021024830A2/pt not_active Application Discontinuation
- 2020-06-11 CA CA3143036A patent/CA3143036A1/en active Pending
- 2020-06-11 MX MX2021015429A patent/MX2021015429A/es unknown
- 2020-06-11 US US17/618,679 patent/US20220249579A1/en not_active Abandoned
- 2020-06-11 WO PCT/US2020/037201 patent/WO2020252144A1/en not_active Ceased
- 2020-06-11 US US17/618,725 patent/US20220296654A1/en not_active Abandoned
- 2020-06-11 EP EP20751724.4A patent/EP3982987A1/en not_active Withdrawn
- 2020-06-11 JP JP2021573327A patent/JP2022538765A/ja active Pending
- 2020-06-11 BR BR112021024754A patent/BR112021024754A2/pt not_active Application Discontinuation
- 2020-06-11 JP JP2021573416A patent/JP2022537684A/ja active Pending
- 2020-06-11 MX MX2021015427A patent/MX2021015427A/es unknown
- 2020-06-11 WO PCT/US2020/037210 patent/WO2020252149A1/en not_active Ceased
- 2020-06-11 TW TW109119718A patent/TW202128198A/zh unknown
- 2020-06-11 CN CN202080042991.3A patent/CN114650831A/zh active Pending
- 2020-06-11 AU AU2020291434A patent/AU2020291434A1/en not_active Abandoned
- 2020-06-11 KR KR1020227000647A patent/KR20220020893A/ko not_active Withdrawn
- 2020-06-11 EP EP20751723.6A patent/EP3982986A1/en not_active Withdrawn
- 2020-06-11 AU AU2020291003A patent/AU2020291003A1/en not_active Abandoned
- 2020-06-11 TW TW109119717A patent/TW202114718A/zh unknown
- 2020-06-11 CN CN202080043264.9A patent/CN114096262A/zh active Pending
-
2022
- 2022-01-05 CO CONC2022/0000041A patent/CO2022000041A2/es unknown
- 2022-01-05 CO CONC2022/0000040A patent/CO2022000040A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537684A5 (https=) | ||
| JP2022538765A5 (https=) | ||
| CN1192151A (zh) | 药用的微胶囊化乳芽孢杆菌 | |
| AU2010308741B2 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| JP2023510158A5 (https=) | ||
| US10016467B2 (en) | Formulations of viable cells for oral delivery | |
| US20060088514A1 (en) | Formulation comprising a bacterial strain | |
| KR101157486B1 (ko) | 경구용 항미생물성 제약학적 조성물 | |
| Bao et al. | Bacteria− based synergistic therapy in the backdrop of synthetic biology | |
| JP2026508600A (ja) | 抗腫瘍治療関連性下痢を予防・治療するプロバイオティクス組成物およびその使用 | |
| WO2003049751A1 (en) | The process of manufacturing a pharmaceutical composition useful for management of cancer | |
| Chen et al. | Living biomaterials: fabrication strategies and biomedical applications | |
| JP4527979B2 (ja) | 癌を治療する方法 | |
| Vejdani et al. | Effects of lactobacillus casei probiotic on mild to moderate ulcerative colitis: a placebo controlled study | |
| US20240366550A1 (en) | Drug for Treating Prostatitis or Benign Prostatic Hyperplasia (BPH) | |
| Bernaś et al. | The use of probiotic Preparations in caries prevention and Treatment | |
| CN116019837B (zh) | 约氏副拟杆菌dsm18315在预防或治疗肥胖或其相关疾病中的应用 | |
| Belal | Relevance of bacterial normal flora in antimicrobial resistance and how to overcome this resistance | |
| US12472216B2 (en) | Compositions comprising bacterial strains and use thereof for the treatment of ocular diseases and lesions | |
| RU93057614A (ru) | Биологический фармакопейный препарат из живых лактобактерий | |
| EP1796700B1 (en) | Eukaryotic based synergistic formulation for gastro-intestinal disorders | |
| Gougoulias et al. | Dietary-based gut flora modulation against Clostridium difficile onset | |
| EP0969851B1 (fr) | Complexe immunomodulateur et son utilisation dans les affections par helicobacter | |
| Liu et al. | The Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications | |
| CN120060007A (zh) | 丁酸梭菌cb24011205及其应用 |